George A. Abdelsayed

  • Los Angeles, CA
  • Urologist
NPI1568721843PAC ID3274758503
Medicare patients, 2024
13
Part D claims, 2024
1,601
Publications
8
Hospital affiliations
1
Industry payments
$3,227
Practice address
4760 W Sunset Blvd, Los Angeles, CA 90027
Practice phone
Call (323) 783-4011
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Southern California Permanente Medical Group

Los Angeles, California

See all 4 affiliations

Find George Abdelsayed's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

George A. Abdelsayed is a urologist in Los Angeles, California

George Abdelsayed practices at Southern California Permanente Medical Group in Los Angeles, California.

George Abdelsayed's NPI, 1568721843, was assigned on May 8, 2012. George Abdelsayed graduated from Keck School of Medicine of USC in 2011. George Abdelsayed holds California license A124694.

NPI and contact details
Medicare PAC ID
3274758503
NPI enumeration date
May 8, 2012
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(323) 783-4011
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
41
Medical school graduation
2011

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

George A. Abdelsayed practices at Southern California Permanente Medical Group in Los Angeles, California

George Abdelsayed's primary practice is Southern California Permanente Medical Group, at 4760 W Sunset Blvd, Los Angeles, CA 90027 in Los Angeles County. The practice phone is (323) 783-4011.

  • Southern California Permanente Medical Group
    4760 W Sunset Blvd, Los Angeles, CA 90027 · Los Angeles CountyPhone(323) 783-4011

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

George A. Abdelsayed is affiliated with 3 sites of care and 1 medical group

George Abdelsayed's primary practice is Southern California Permanente Medical Group in Los Angeles, California. George Abdelsayed is also affiliated with Kaiser Permanente Los Angeles Medical Center. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links George Abdelsayed to 1 more group practice or clinic, named with a free account.

See all 4 affiliations for George Abdelsayed

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at George A. Abdelsayed's practice

Dmand AI tracks the electronic health record (EHR) system at each site where George Abdelsayed practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Southern California Permanente Medical GroupAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where George Abdelsayed practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

George A. Abdelsayed is one of 1,395 urologists in California

Urology is George Abdelsayed's primary specialty in the NPI Registry, under taxonomy code 208800000X. George Abdelsayed is board certified in urology by the American Board of Urology. Dmand AI has George Abdelsayed's licenses on file in 2 states: California and Illinois.

Specialties and state licenses

  • Urology, CaliforniaPrimaryLicense A124694 · 2013 to 2027 · taxonomy 208800000X
  • Illinois licenseLicense 036.143791 · 2017 to 2023

Urologists near George Abdelsayed

Counts of urologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

George A. Abdelsayed treated 13 Medicare patients in 2024, average age 67

CMS counts 13 Medicare patients who saw George Abdelsayed in 2024. The largest group is 85 and over, with 0 patients. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts George Abdelsayed's median patient age at 63, with 4% women.

Medicare patients, 202413
Average age67
Average risk score1.28

George Abdelsayed's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

George Abdelsayed's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 63

Patient panel by sex, all payers

  • Women4%
  • Men96%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

George A. Abdelsayed wrote 1,601 Medicare Part D claims in 2024

In 2024, George Abdelsayed wrote 1,601 Medicare Part D claims for 362 patients. 81% of them were for generic drugs. CMS names the drug for 1,508 of them, across 16 drugs with 11 or more claims each, at $321,100 in total drug cost. In 2023, CMS named 1,411 claims across 17 drugs.

Part D claims, 20241,601
Drugs named by CMS16
Total drug cost$321,100
Part D patients362

George Abdelsayed's Part D claims by kind of drug, 2024

  • Generic1,302 claims81%
  • Brand-name269 claims17%
  • Other30 claims2%

George Abdelsayed's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in George Abdelsayed's Part D claims, 2024

  • Antibiotics5%84 of 1,601 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,4112024: 1,5087%

Drugs named by CMS: 16 in 2024, 17 in 2023.

See all prescribing by George Abdelsayed

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How George A. Abdelsayed takes part in Medicare

George Abdelsayed accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find urologists like George Abdelsayed by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

George A. Abdelsayed has 8 publications on record

Dmand AI links 8 papers to George Abdelsayed, published from 2017 to 2019. 2018 was the busiest year, with 3. The most frequent topics are Patient Satisfaction, Penis and Erectile Dysfunction. George Abdelsayed has published most often in J Sex Med. George Abdelsayed's most frequent co-authors are Laurence Adan Levine, MD, Patrick Sean Kilday, MD and Pooya Banapour.

Papers8
Years published2017 to 2019

George Abdelsayed's papers by year, 2017 to 2019

Topics George Abdelsayed writes about most

  • Patient Satisfaction
  • Penis
  • Erectile Dysfunction
  • Penile Implantation
  • Penile Induration
  • Penile Prosthesis

George Abdelsayed's most frequent co-authors

Recent publications by George Abdelsayed

See all 8 publications and co-authors

See who George Abdelsayed researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who George Abdelsayed works with, so you can find a warm path to the right urologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

George A. Abdelsayed received $3,227 in industry payments from 2016 to 2025

CMS Open Payments shows 41 general payments to George Abdelsayed from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Boston Scientific Corporation paid the most, $1,635.

General payments to George Abdelsayed by program year, 2016 to 2025

General payments to George Abdelsayed by kind, 2016 to 2025

$3.2Kin total
  • Food and beverage$2,94191%
  • Education$2869%

Companies that paid George Abdelsayed the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to George Abdelsayed

Source: Open Payments (CMS), 2025 data, released July 7, 2026

George A. Abdelsayed graduated from Keck School of Medicine of USC

George Abdelsayed graduated from Keck School of Medicine of USC in 2011. George Abdelsayed is a member of AUA.

  1. Medical schoolKeck School of Medicine of USC
  2. Board certified in urologyAmerican Board of Urology

Source: Dmand AI Professional Profile Data

George A. Abdelsayed accepts plans from 2 insurance carriers

George Abdelsayed is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.

  • Kaiser Permanente
  • CMS Medicare

Plan types George Abdelsayed accepts, by number of carriers

  1. EPO1
  2. HMO1
  3. Medicare1
  4. POS1

Source: Dmand AI Insurance Network Data

Sources for George A. Abdelsayed's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about George A. Abdelsayed

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is George A. Abdelsayed's NPI number?

George A. Abdelsayed's NPI number is 1568721843. It was assigned on May 8, 2012, and it is active in the NPI Registry.

What does George A. Abdelsayed specialize in?

George A. Abdelsayed is a urologist in Los Angeles, California. The primary specialty in the NPI Registry is Urology Physician (taxonomy code 208800000X).

Where does George A. Abdelsayed practice?

George Abdelsayed practices at 4760 W Sunset Blvd, Los Angeles, CA 90027. George Abdelsayed's primary practice is Southern California Permanente Medical Group in Los Angeles, California. Dmand AI also links George Abdelsayed to 1 group practice or clinic.

What is George A. Abdelsayed's office phone number?

The practice phone on file for George Abdelsayed is (323) 783-4011.

What is George A. Abdelsayed's medical license number?

George Abdelsayed holds California license A124694, one of the licenses on file in 2 states.

Which states has George A. Abdelsayed been licensed in?

Dmand AI has state licenses on file for George Abdelsayed in California (2013 to 2027) and Illinois (2017 to 2023).

Which hospitals is George A. Abdelsayed affiliated with?

George Abdelsayed is affiliated with Kaiser Permanente Los Angeles Medical Center.

What medical group is George A. Abdelsayed part of?

George Abdelsayed is linked to Southern California Permanente Medical Group.

Does George A. Abdelsayed accept Medicare?

Yes. CMS lists George Abdelsayed as accepting Medicare assignment.

How many Medicare patients does George A. Abdelsayed see?

CMS counts 13 Medicare patients who saw George Abdelsayed in 2024, with an average age of 67.

Show 8 more questionsShow fewer questions

Is George A. Abdelsayed board certified?

Yes. George Abdelsayed is board certified in urology by the American Board of Urology.

Where did George A. Abdelsayed go to medical school?

George Abdelsayed graduated from Keck School of Medicine of USC in 2011.

What drugs does George A. Abdelsayed prescribe most?

In 2024 Medicare Part D data, George Abdelsayed's most prescribed drugs by claims were Tamsulosin HCl, Finasteride and Myrbetriq.

Has George A. Abdelsayed received payments from drug or device companies?

CMS Open Payments shows $3,227 in general payments to George Abdelsayed from 8 companies from 2016 to 2025. The largest total came from Boston Scientific Corporation.

How long has George A. Abdelsayed been practicing?

George Abdelsayed graduated from medical school in 2011, 15 years ago.

Does George A. Abdelsayed do research?

Dmand AI links 8 publications to George Abdelsayed, published from 2017 to 2019.

Who does George A. Abdelsayed publish with?

George Abdelsayed's most frequent co-authors are Laurence Adan Levine, MD (4 shared papers), Patrick Sean Kilday, MD (2 shared papers) and Pooya Banapour (1 shared paper).

What insurance does George A. Abdelsayed accept?

George Abdelsayed is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.

Selling to urology practices?

See urologists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)